4.7 Article

Deficient emotional self-regulation and pediatric attention deficit hyperactivity disorder: a family risk analysis

Journal

PSYCHOLOGICAL MEDICINE
Volume 42, Issue 3, Pages 639-646

Publisher

CAMBRIDGE UNIV PRESS
DOI: 10.1017/S0033291711001644

Keywords

ADHD; deficient emotional self-regulation; pediatric

Funding

  1. Shire Pharmaceuticals
  2. Elminda
  3. Janssen
  4. McNeil
  5. Next Wave Pharmaceuticals
  6. Shire
  7. Fundacion Dr Manuel
  8. Cipher Pharmaceuticals Inc.
  9. Fundacion Areces
  10. Medice Pharmaceuticals
  11. Spanish Child Psychiatry Association
  12. Abbott
  13. Alza
  14. Bristol-Myers Squibb
  15. Celltech
  16. Cephalon
  17. Eli Lilly and Co.
  18. Esai
  19. Forest
  20. Glaxo
  21. Gliatech
  22. Merck
  23. NARSAD
  24. NIDA
  25. New River
  26. NICHD
  27. NIMH
  28. Novartis
  29. Noven
  30. Neurosearch
  31. Organon
  32. Otsuka
  33. Pfizer
  34. Pharmacia
  35. Prechter Foundation
  36. Stanley Foundation
  37. UCB Pharma, Inc.
  38. Wyeth
  39. Shire Laboratories, Inc
  40. Eli Lilly Company
  41. GlaxoSmithKline
  42. Janssen Pharmaceutical
  43. McNeil Pharmaceutical
  44. Novartis Pharmaceuticals
  45. National Institute of Mental Health
  46. National Institutes of Health (NIH)
  47. Guilford Press

Ask authors/readers for more resources

Background. Although deficient emotional self-regulation (DESR) is associated with attention deficit hyperactivity disorder (ADHD), little research investigates this association and little is known about its etiology. Family studies provide a method of clarifying the co-occurrence of clinical features, but no family studies have yet addressed ADHD and DESR in children. Method. Subjects were 242 children with ADHD and 224 children without ADHD. DESR was operationalized using an aggregate score >= 180 and <210 in the anxious/depressed, attention and aggression scales (AAA profile) of the Child Behavior Checklist (CBCL), termed the CBCL-DESR profile. The CBCL-bipolar (CBCL-BP) profile was defined as >= 210 on the CBCL-AAA scale. We examined the familial transmission of ADHD and the CBCL-AAA scale in families selected through probands with and without these conditions. Results. We found a linear increase in the prevalence of CBCL-DESR in siblings as indexed by the Control, ADHD, ADHD + CBCL-DESR and ADHD + CBCL-BP proband groups. While the ADHD siblings were at elevated risk for both the CBCL-DESR and CBCL-BP compared with non-ADHD siblings, a significantly higher rate of CBCL-BP in the siblings of ADHD + CBCL-BP probands was found compared with siblings of the Control probands. Conclusions. ADHD shows the same degree of familial transmission in the presence or absence of DESR. CBCL-DESR and CBCL-BP are familial, but further work is needed to determine if these definitions are distinctly familial or represent a continuum of the same psychopathology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available